!— Global site tag (gtag.js) - Google Analytics —>
Nonggongdanji-gil, Hongcheon-eup, Hongcheon-gun, Gangwon-do, Republic of Korea
ContactGet in touch helps us to
understand you better
|ADDRESS||23-16, Nonggongdanji-gil, Hongcheon-eup, Hongcheon-gun, Gangwon-do, Republic of Korea|
|ADDRESS||Room 916, Blue zone,150, Jojeong-daero, Hanam-si, Gyeonggi-do, Republic of Korea|
|ADDRESS||3rd floor, 639, Seolleung-ro, Gangnam-gu, Seoul, Republic of Korea|
|ADDRESS||Room 1005, Building No.1, No.7001 Zhongchun Road, MinhangDistrict, 201101 Shanghai China|
Although current definitions exclude these products from the ‘Probiotics’ category,
we propose that microbial-derived molecules with health benefits could be included
in a sub-category termed “Pharmabiotics” within probiotics.
One-stop industrialization platform based on
Immunomodulatory technology based on
human microbiome analysis.
Cell factory and drug delivery system
based on engineered Bifidobacterium.
Beyond the functionality of probiotics, its pharmaceutical role is drawing attention around the world. We are continuously conducting human research to prove the effects of the Pharmabiotics in collaboration with university hospitals.
Improvement of cognitive function,
memory and depression in the elderly
Seoul National University
Decreased incidence of eczema in infants
Samsung Hospital Pediatrics
Combination therapy Improved treatment
effect for ulcerative colitis
Medical school of Palermo University Italy
Improving immunity and inflammation
indicators in kidney dialysis patients
Korea University Hospital Internal Medicine
Composition containing bifidobaccterium for
alleviating, preventing of treating RA
Catholic Hospital Internal Medicine
Improvement of nasal congestion
and rhinitis symptoms
Seoul National University Internal Medicine
Currently, Bifido Co,. Ltd is performing research for the development of the pharmaceutical Bifidobacterium strain suppressing rheumatoid arthritis (RA) in collaboration with Catholic Hospital RA Center.
Composition for improving, treating or preventing rheumatoid arthritis containing Bifidobacterium
(Korea Patent No.: 10-2074445)
Composition containing bifidobaccterium for alleviating, preventing of treating RA
(US Patent No.: US 10,617,725 B2)